TGA seeks input on benzocaine advisory statements

The Therapeutic Goods Administration (TGA) has requested comments from interested parties on the addition of a new advisory statement for labels of non-prescription medicines...

How culturally safe is your pharmacy?

This National Reconciliation Week (27 May–3 June), PSA Senior Pharmacist Megan Tremlett encourages pharmacists to change their perspective on Aboriginal and Torres Strait Islander communities to improve end-of-life care.

How much fish oil is enough?

Many patients use fish oil in the hope of relief from inflammatory conditions or to reduce risks of cardiovascular disease.  As non-prescription complementary medicines,...

Heading off patient harm from medicines

Medicine adherence, deprescribing and establishing systems to prevent error recurrence are all part of the pharmacist’s calling to protect patient safety. Pharmacists, as custodians of...

Repackaged medicines: are patients storing them correctly?

Patients often find creative ways to remember to take their medicines. These might include alarms and reminder apps or placing medicines in visible locations...

Noradrenaline reuptake inhibitors and schizophrenia

Schizophrenia is a chronic illness characterised by a range of symptoms including positive and negative symptoms. Examples of positive symptoms include hallucinations, delusions, and...